| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | UHNBreast | pan-cancer | AAC | -0.82 | 0.001 |
| mRNA | Sorafenib | FIMM | pan-cancer | AAC | -0.51 | 0.01 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.41 | 0.2 |
| mRNA | Cyclopamine | FIMM | pan-cancer | AAC | -0.38 | 0.04 |
| mRNA | Sunitinib | FIMM | pan-cancer | AAC | -0.37 | 0.1 |
| mRNA | Bicalutamide | FIMM | pan-cancer | AAC | -0.36 | 0.09 |
| mRNA | Axitinib | FIMM | pan-cancer | AAC | -0.35 | 0.08 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.33 | 0.04 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.32 | 0.3 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.31 | 0.2 |